论文部分内容阅读
近年来,不仅镁的抗心律失常作用已受到重视,而且它对损伤心肌的保护作用一一缩小梗塞心肌面积,减少急性心肌梗塞(AMI)死亡率方面的有益效应,也逐渐得到证实。为此,我们对74名AMI病人进行了硫酸镁极化液治疗组(简称治疗组)与极化液对照组(简称对照组)的单盲、随机分组临床观察。资料与方法一、对象:我们对1988.6～1991.2月以AMI入院的74名患者,立即随机分为治疗组与对照组进行治疗观察,病人均符合WHO AMI诊标标准。(1)治疗组:36例,男24例、女12例,年龄40～82岁,平均65.8±12岁,并高血压者10人,糖尿病4人,高血脂6人,有吸烟史10人,以往有心肌梗塞史者5人。
In recent years, not only the anti-arrhythmic effect of magnesium has been taken seriously, but also its protective effects on injured myocardium reduce the area of infarcted myocardium one by one and reduce the beneficial effect of acute myocardial infarction (AMI) mortality has gradually been confirmed. To this end, we have 74 patients with AMI magnesium sulfate polarization solution treatment group (referred to as the treatment group) and the polarization fluid control group (referred to as the control group) single-blind, randomized clinical observation. Materials and Methods I. Object: We evaluated 74 patients admitted to AMI from 1988.6 to 1991.2 months and were randomly divided into treatment group and control group for treatment. All patients met WHO AMI standard. (1) The treatment group: 36 cases, 24 males and 12 females, aged 40-82 years with an average age of 65.8 ± 12 years, 10 with hypertension, 4 with diabetes, 6 with hyperlipidemia and 10 with smoking history , Past history of myocardial infarction in 5.